NEW YORK (GenomeWeb News) – Under a new set of recommendations for molecular genetic testing companies, the US Centers for Disease Control and Prevention said that firms should provide specific information to users of its tests, should measure certain analytic performance specifications, and should adhere to certain informed consent and specimen handling rules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.